The India nebulizers market was valued at INR 575.6 million in 2014 and is estimated to reach a market worth of INR 4,703.4 million in 2023 growing at a CAGR of 25.8% from 2015 to 2023.
A nebulizer is an electrically powered (mostly) or battery operated instrument that converts liquid medication into mist or aerosol which can easily reach into the lungs of a patient when inhaled through a mouthpiece or a face mask. Rising prevalence of various respiratory disorders such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD) and increasing geriatric population boost the growth of the nebulizers market in India. Aging population are more prone to respiratory disease; people above the age of 60 years have 70% risk of developing asthma and chronic obstructive pulmonary diseases. Nebulizers market in India was valued at INR 575.6 million in 2014 and is projected to reach INR 4,703.4 million by 2023, expanding at a CAGR of 25.8% during the forecast period from 2015 to 2023.
In 2014, pneumatic nebulizer accounted for the largest market share of 68% of the nebulizers market in India owing to its cost effective and easy to handle nature. Moreover, pneumatic nebulizers are most widely used due to its suitability towards all types of medications hence these factors would further drive the pneumatic nebulizers market during the forecast period. The ultrasonic nebulizers are more effective and efficient compared to vented pneumatic nebulizers. Faster drug delivery and less chances of drug loss during exhalation are the major factors driving the demand for ultrasonic nebulizers. However, factors such as high price, drug inactivation due to high ultrasonic wave created by the instrument are certain drawbacks of the ultrasonic nebulizers which would hamper the growth of ultrasonic nebulizers. Mesh nebulizers held the highest CAGR in the India nebulizers market. Mesh nebulizers perform efficient and fast drug delivery. Moreover, these are small devices equipped with recent technology which can run on rechargeable batteries. These factors are driving the demand for mesh nebulizers in the country.
According to India’s National Health Profile 2015, around 3.5 million cases of acute respiratory infection (ARI) were reported in 2014, an increase by 140,000 compared to 2013, and a 30% increase since 2010. North Zone was the largest market for nebulizers in 2014, accounting for a share of 35.60% in terms of revenue. Rise in environmental pollution has led to an increase in respiratory diseases in this region. According to the World Health Organization, New Delhi was the world’s most polluted city, measured by PM2.5, with an annual average of 153 micrograms per cubic meter in 2014. The nebulizers market in South Zone is growing at a constant rate, with Bangalore and Chennai accounting for the major share of the market. Rising prevalence of respiratory diseases over the last decade and high acceptance of innovative drug delivery route among the population would boost market growth. East zone was the second largest market in terms of revenue in 2014. The market is shifting from traditional drug delivery route to innovative methods of drug delivery. High acceptance of these methods is likely to boost market growth. Moreover, according to West Bengal's department of environment, 70% of Kolkata's citizen suffer from some form of respiratory disease due to rise in environmental pollution. This acts as a potential driver of the nebulizers market in East Zone. West zone and central zone were the upcoming market in the India nebulizers market. Rising environmental pollution in cities such as Mumbai, Pune, and Ahmedabad increases the incidence of respiratory and COPD diseases. A study by the Indian Institute of Environmental Medicine (IIEM) revealed that the percentage of people in Mumbai and Thane suffering from COPD is much higher than the all-India figure of 4.1%. Hence, these factors would fuel the market growth of nebulizers in India during the forecast period.
Download Brochure:
Omron Healthcare dominated the India nebulizers market in 2014. Major factors attributed to its dominance are broad product portfolio and high market penetration. Omron’s models are accurate, high quality and simple to use. Philips Healthcare was the second leading player in the India nebulizers market in 2014. Other players operating the market include CareFusion (BD), Morepen Laboratories Ltd, Agilent Technologies, Inc., DeVilbiss Healthcare LLC, Nulife (MRK Healthcare Pvt. Ltd.), PARI Respiratory Equipment, Inc., and others.
GermanForce
Thema drucken
11.02.2019 02:50
Antworten
